Efficacy, semantic and chemotherapy in advanced NSCLC
- 1 April 1994
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 5 (4) , 303-304
- https://doi.org/10.1093/oxfordjournals.annonc.a058828
Abstract
Silvia Marsoni, Maurizia Clerici; Efficacy, semantic and chemotherapy in advanced NSCLC, Annals of Oncology, Volume 5, Issue 4, 1 April 1994, Pages 303–304, htThis publication has 8 references indexed in Scilit:
- Comparison of two chemotherapeutic regimens − mitomycin + vindesine 4-cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP) − in advanced non-small-cell lung cancerAnnals of Oncology, 1994
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994
- Chemotherapy of non-small cell lung cancerAnnals of Oncology, 1993
- Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancerAnnals of Oncology, 1993
- Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?Journal of Clinical Oncology, 1993
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Cisplatin-Cyclophosphamide-Mitomycin Combination Chemotherapy With Supportive Care Versus Supportive Care Alone for Treatment of Metastatic Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- Signiicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung CarcinomaJNCI Journal of the National Cancer Institute, 1992